Cargando…
Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals
BACKGROUND: The first line anti-tuberculosis drugs isoniazid (INH), rifampicin (RIF) and pyrazinamide (PZA) continues to be the effective drugs in the treatment of tuberculosis, however, the use of these drugs is associated with toxic reactions in tissues, particularly in the liver, leading to hepat...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491620/ https://www.ncbi.nlm.nih.gov/pubmed/18601745 http://dx.doi.org/10.1186/1743-7075-5-18 |